Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMF in IgA Nephropathy
NCT00318474Phase 3Terminated
- Sponsor
- St. Joseph's Hospital and Medical Center
- Start
- Jan 2002
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mycophenolate mofetil in IgA nephropathy (IgAN), sponsored by St. Joseph's Hospital and Medical Center. Started Jan 2002; status: terminated.
02
Drugs
mycophenolate mofetil
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT00318474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00318474.